Skip to main content
  • LinkedIn
  • Instagram
  • Facebook
  • YouTube
  • Email
  • People
  • Events
  • News
National Cancer Institute
Home
Frederick National Laboratory
Menu

Mega Menu

  • Research & Technology
    • Science Areas
      • AIDS and Cancer Virus Program
        • Program Overview
        • Sections
          • Retroviral Evolution Section
          • Retroviral Pathogenesis Section
          • Retrovirus-Cell Interaction Section
          • Viral Oncology Section
          • Viral Persistence Section
        • Cores
          • Biological Products Core
          • Cellular Immunity Core
          • HIV Molecular Monitoring Core
          • Nonhuman Primate Research Support Core
          • Quantitative Molecular Diagnostics Core
          • Tissue Analysis and Retroviral Protein Chemistry Core
          • Viral Evolution Core
      • Basic Science Program
        • Program Overview
        • Experimental Structural Biology Section
        • Computational Structural Biology Section
        • Epigenetics Section
        • HLA Immunogenetics Section
        • Molecular Immunology Section
      • Bioinformatics and Computational Science
        • Program Overview
        • Advanced Biomedical Computational Science
        • Center for Technical Operations Support
      • Cancer Research Technology Program
        • Program Overview
        • Advanced Cryo-Electron Microscopy Technology Group
        • Antibody Characterization Laboratory
        • CLIA Molecular Diagnostics Laboratory
        • Imaging Mass Cytometry Laboratory
        • Molecular Pharmacology Program
        • Protein Expression Laboratory
      • Laboratory Animal Sciences Program
        • Program Overview
        • Animal Diagnostics Laboratory
        • Animal Research Technical Support
        • Genome Modification Core
        • Gnotobiotics Facility
        • Laboratory Animal Medicine
        • Molecular Histopathology Laboratory
        • Mouse Modeling and Cryopreservation
        • Small Animal Imaging Program
      • Vaccine, Immunity, and Cancer Directorate
        • Program Overview
        • Cancer Immunoprevention Laboratory
        • HPV Serology Laboratory
      New initiative housed at FNL

      NIH establishes nation's first dedicated organoid development center to reduce reliance on animal modeling

      The Standardized Organoid Modeling Center aims to produce standardized protocols for organoid research, addressing reproducibility challenges.
    • Clinical Trial Support
      • Applied and Developmental Research Directorate
        • Program Overview
        • Clinical Services Program
          • AIDS Monitoring Laboratory
          • Bioprocessing Laboratory
          • Blood Processing Core
          • Clinical Support Laboratory
          • Flow Cytometry Support Laboratory
          • Immunological Monitoring Laboratory
          • Laboratory of Human Retrovirology and Immunoinformatics
          • Laboratory of Molecular Cell Biology
          • Neutrophil Monitoring Laboratory
          • Radiochemistry Program
          • Virus Isolation and Serology Laboratory
        • DCTD Support
          • Cancer Imaging Informatics Laboratory
          • Clinical Pharmacodynamics - Biomarkers Program
          • In Vitro Evaluation and Molecular Pharmacology Laboratories
          • In Vivo Evaluation Program
          • Investigative Toxicology Laboratory
          • NExT Chemical Biology Consortium Support Programs
          • Natural Products Support Group
          • Pharmacokinetics and Drug Analysis Group
          • Radiochemistry Support Group
      • Biopharmaceutical Development Program
      • Clinical Monitoring Research Program
      • Clinical Research Directorate
        • Program Overview
        • Biospecimen Research Group
        • Cancer Genomics Research Laboratory
        • Drug Discovery and Development Program
        • Molecular Characterization Laboratory
      • Vaccine Clinical Materials Program
      myeloMATCH

      New rapid assay developed to support medicine trial for blood cancers

      Scientists developed a new, precise assay to detect cancer-driving mutations in myeloMATCH precision medicine trials.
    myeloMATCH

    New rapid assay developed to support medicine trial for blood cancers

    Scientists developed a new, precise assay to detect cancer-driving mutations in myeloMATCH precision medicine trials.
  • Innovation & Initiatives
    • Initiatives
      • RAS Initiative
        • Program Overview
        • Biochemistry & Biophysics Research Team
        • Bioinformatics Research Team
        • Chemistry Research Team
        • Computational Chemistry Research Team
        • Drug Screening and Preclinical Research Team
        • Imaging Research Team
        • Mass Spectrometry Research Team
        • Reagents Research Team
        • Structural Biology Research Team
      • Scientific Standards Hub
      Did you know?
      About 30% of all human cancers are driven by mutations of the RAS family of genes. The RAS Initiative endeavors to better understand the RAS oncogene and discover its vulnerabilities to treat RAS-related cancers.
    • Innovation
      • Center for Innovation and Strategic Partnerships
      • Patents
      Importance of innovation Within FNL, innovation plays a pivotal role in delivering new and enhanced technologies that empower us to tackle essential scientific inquiries, enhance our services, and ultimately contribute to the wellbeing of patients.
      Vladimir Popov, Ph.D., MBA
    • Scientific Series
      • Biotech Connector
      • High Fidelity
      • Life Sciences Symposium
      • RAS Initiative Symposium
      • Scientific Partners Distinguished Lecture Series
      • Technology Showcase
      • Women in Science Speak
    LZTR1-KRAS affinity

    Exploiting cellular degradation machinery as a potential treatment strategy for RAS-driven cancers

    In a recent study, the Frederick National Laboratory team used the X-ray crystallography technique to reveal the atomic details of how LZTR1 interacts with different RAS family members, including RIT1, MRAS and KRAS.
  • Investigator Resources
    • All Resources
    • Data & Repositories
      • BRB Preclinical Biologics Repository
      • MHL Immunohistochemistry Database
      • RAS Reagents & Tools
      • dbGuide
      • sgRNA Scorer
      • More Repositories
      SIV/SHIV

      Barcode Analysis Tool

      Download files to demultiplex next-generation sequencing and determine the abundance of individually barcoded SIV/SHIV viral lineages.
    • National Scientific User Facilities
      • Nanotechnology Characterization Laboratory
      • National Cryo-Electron Microscopy Facility
      Assay Cascade Characterization Program

      Next deadline to apply: March 2, 2026

      Preclinical characterization of nanoparticles to facilitate the regulatory review of nanotechnology concepts intended as cancer therapies and diagnostics.
    • Training & Education
      • cGMP Training
      • FNL Global Clinical Research Educational Modules
      • Project Management Night Out Seminar Series
      Ways of Working Dec 10, 2025

      Project Managing Your Way to a Less Stressful Week

      Michellene Kerr-Gordon will share how a project management mindset can help relieve stress by adapting classic tools, techniques, and strategies to manage our busy lives.
    • Technical Services
      • Program Overview
      • HIV/SIV Services
        • Cellular or Tissue SIV/SHIV RNA and DNA testing
        • HIV/SIV Single Genome Amplification and Sequencing
        • Lineage-specific Next Gen Multiplex In Situ Hybridization for HIV or SIV RNA and DNA
        • Next-generation sequencing analysis of barcoded SIV, SHIV, or HIV
        • Novel CD4+ T Cell Specific Immunohistochemistry Detection and Analysis
        • Plasma or CSF SIV/SHIV RNA measurements
        • Quantitative Assessment of Lymphoid Tissue Fibrosis
        • Quantitative assessment of HIV or SIV viral DNA in laser capture microdissected immune cells
        • Viral Integration Site Analysis (VISA) for HIV studies
      • Nanomedicine & Nanoformulation
        • An in vitro drug release study in human plasma
        • Pharmacokinetic study of nanomedicine in rats
      • Other
        • Detection of Mycobacterium tuberculosis DNA
        • TypeSeq2 HPV genotyping services
      Did you know?
      We are home to unique scientific expertise and technological capabilities available nowhere else. The Technical Services Program through the Partnership Development Office makes some of these capabilities and services readily available to the external research community at-cost to advance biomedical research around the world.
    • Universal Standards & Reference Materials
      • AI and Data Science
      • Antibody Science
      • Biospecimen Assays
      • Biopharmaceutical Development
      • Electron Microscopy
      • Serology Operating Procedures
      • Human SARS-CoV-2 Serology Standard
      • Nanotechnology
      • Protein Science
      FNL Initiative

      Scientific Standards Hub

      Collection of scientific groups at FNL working to develop, deposit and share standards and references in biological research.
    Training

    FNL Global Clinical Research Educational Modules

    Learn about challenges in clinical research during emergency infectious disease outbreaks and strategies to overcome them.
  • Work With Us
    • Collaboration
      • Partnership Development Office
      • Partnership Mechanisms
      • Academic Partnerships

      Biotech Connector reimagines the future of gene and cell-based therapies

      Frederick’s biotech innovators discussed how they're revolutionizing gene and cell therapies through cutting-edge manufacturing, streamlined supply chains, and powerful automation.
    • Tech Transfer & Licensing
      • Intellectual Property and Strategic Agreements
      Innovation

      FNL Patents

      Technologies invented and patented by researchers at the Frederick National Laboratory
    • Vendors & Subcontractors
      • Become a Vendor
      • Business Opportunities
      • Contracts and Acquisitions
      • Small Businesses, Nonprofits & HBCUs
    Register Your Interest

    Become a Vendor

    Potential vendors seeking to work with us must first complete a New Vendor Registration.
  • Careers
    • Job Opportunities
    • Application Process
    • Benefits
    • Internships and Fellowships
    Brilliant teamwork The team here is made up of brilliant scientists. Coming from a diverse research background myself, it’s inspiring to be in a room where everyone contributes something unique. I feel truly privileged to be part of it.
    Samarth Mathur, Ph.D.
  • About FNL
    • Who We Are
    • Mission & Core Values
    • Community Outreach
    • People
    • Publications
    • History
    Did you know?
    Biopharmaceutical Development Program manufactures CAR T-cell treatment for NCI phase 1 pediatric clinical trials.

Amy Hutchinson

Operations Director, Cancer Genomics Research Laboratory
Frederick National Laboratory logo Frederick National Laboratory for Cancer Research is operated by Leidos Biomedical Research, Inc. for the National Cancer Institute.
  • LinkedIn
  • Instagram
  • Facebook
  • YouTube
  • Email

Quick Links

  • Contact Us
  • Accessibility
  • Conflict of Interest
  • Privacy Policy
  • HHS Vulnerability Disclosure
National Cancer Institute
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute
  • USA.gov
  • Research & Technology
    • Science Areas
      • AIDS and Cancer Virus Program
        • Sections
          • Retroviral Evolution Section
          • Retroviral Pathogenesis Section
          • Retrovirus-Cell Interaction Section
          • Viral Oncology Section
          • Viral Persistence Section
        • Cores
          • Biological Products Core
          • Cellular Immunity Core
          • HIV Molecular Monitoring Core
          • Nonhuman Primate Research Support Core
          • Quantitative Molecular Diagnostics Core
          • Tissue Analysis and Retroviral Protein Chemistry Core
          • Viral Evolution Core
      • Basic Science Program
        • Experimental Structural Biology Section
        • Computational Structural Biology Section
        • Epigenetics Section
        • HLA Immunogenetics Section
        • Molecular Immunology Section
      • Bioinformatics and Computational Science
        • Advanced Biomedical Computational Science
        • Center for Technical Operations Support
      • Cancer Research Technology Program
        • Advanced Cryo-Electron Microscopy Technology Group
        • Antibody Characterization Laboratory
        • CLIA Molecular Diagnostics Laboratory
        • Imaging Mass Cytometry Laboratory
        • Molecular Pharmacology Program
        • Protein Expression Laboratory
      • Laboratory Animal Sciences Program
        • Animal Diagnostics Laboratory
        • Animal Research Technical Support
        • Genome Modification Core
        • Gnotobiotics Facility
        • Laboratory Animal Medicine
        • Molecular Histopathology Laboratory
        • Mouse Modeling and Cryopreservation
        • Small Animal Imaging Program
      • Vaccine, Immunity, and Cancer Directorate
        • Cancer Immunoprevention Laboratory
        • HPV Serology Laboratory
    • Clinical Trial Support
      • Applied and Developmental Research Directorate
        • Clinical Services Program
          • AIDS Monitoring Laboratory
          • Bioprocessing Laboratory
          • Blood Processing Core
          • Clinical Support Laboratory
          • Flow Cytometry Support Laboratory
          • Immunological Monitoring Laboratory
          • Laboratory of Human Retrovirology and Immunoinformatics
          • Laboratory of Molecular Cell Biology
          • Neutrophil Monitoring Laboratory
          • Radiochemistry Program
          • Virus Isolation and Serology Laboratory
        • DCTD Support
          • Cancer Imaging Informatics Laboratory
          • Clinical Pharmacodynamics - Biomarkers Program
          • In Vitro Evaluation and Molecular Pharmacology Laboratories
          • In Vivo Evaluation Program
          • Investigative Toxicology Laboratory
          • NExT Chemical Biology Consortium Support Programs
          • Natural Products Support Group
          • Pharmacokinetics and Drug Analysis Group
          • Radiochemistry Support Group
      • Biopharmaceutical Development Program
      • Clinical Monitoring Research Program
      • Clinical Research Directorate
        • Biospecimen Research Group
        • Cancer Genomics Research Laboratory
        • Drug Discovery and Development Program
        • Molecular Characterization Laboratory
      • Vaccine Clinical Materials Program
  • Innovation & Initiatives
    • Initiatives
      • RAS Initiative
        • Biochemistry & Biophysics Research Team
        • Bioinformatics Research Team
        • Chemistry Research Team
        • Computational Chemistry Research Team
        • Drug Screening and Preclinical Research Team
        • Imaging Research Team
        • Mass Spectrometry Research Team
        • Reagents Research Team
        • Structural Biology Research Team
      • Scientific Standards Hub
    • Innovation
      • Center for Innovation and Strategic Partnerships
      • Patents
    • Scientific Series
      • Biotech Connector
      • High Fidelity
      • Life Sciences Symposium
      • RAS Initiative Symposium
      • Scientific Partners Distinguished Lecture Series
      • Technology Showcase
      • Women in Science Speak
  • Investigator Resources
    • All Resources
    • Data & Repositories
      • BRB Preclinical Biologics Repository
      • MHL Immunohistochemistry Database
      • RAS Reagents & Tools
      • dbGuide
      • sgRNA Scorer
      • More Repositories
    • National Scientific User Facilities
      • Nanotechnology Characterization Laboratory
      • National Cryo-Electron Microscopy Facility
    • Training & Education
      • cGMP Training
      • FNL Global Clinical Research Educational Modules
      • Project Management Night Out Seminar Series
    • Technical Services
      • Program Overview
      • HIV/SIV Services
        • Cellular or Tissue SIV/SHIV RNA and DNA testing
        • HIV/SIV Single Genome Amplification and Sequencing
        • Lineage-specific Next Gen Multiplex In Situ Hybridization for HIV or SIV RNA and DNA
        • Next-generation sequencing analysis of barcoded SIV, SHIV, or HIV
        • Novel CD4+ T Cell Specific Immunohistochemistry Detection and Analysis
        • Plasma or CSF SIV/SHIV RNA measurements
        • Quantitative Assessment of Lymphoid Tissue Fibrosis
        • Quantitative assessment of HIV or SIV viral DNA in laser capture microdissected immune cells
        • Viral Integration Site Analysis (VISA) for HIV studies
      • Nanomedicine & Nanoformulation
        • An in vitro drug release study in human plasma
        • Pharmacokinetic study of nanomedicine in rats
      • Other
        • Detection of Mycobacterium tuberculosis DNA
        • TypeSeq2 HPV genotyping services
    • Universal Standards & Reference Materials
      • AI and Data Science
      • Antibody Science
      • Biospecimen Assays
      • Biopharmaceutical Development
      • Electron Microscopy
      • Serology Operating Procedures
      • Human SARS-CoV-2 Serology Standard
      • Nanotechnology
      • Protein Science
  • Work With Us
    • Collaboration
      • Partnership Development Office
      • Partnership Mechanisms
      • Academic Partnerships
    • Tech Transfer & Licensing
      • Intellectual Property and Strategic Agreements
    • Vendors & Subcontractors
      • Become a Vendor
      • Business Opportunities
      • Contracts and Acquisitions
      • Small Businesses, Nonprofits & HBCUs
  • Careers
    • Job Opportunities
    • Application Process
    • Benefits
    • Internships and Fellowships
  • About FNL
    • Who We Are
    • Mission & Core Values
    • Community Outreach
    • People
    • Publications
    • History